Storia in 8 fonti

FDA approves Mounjaro to lower heart attack and stroke risk

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

qz.comStai leggendo1 g fa

FDA approves Mounjaro to lower heart attack and stroke risk

The diabetes drug, already the top-prescribed branded type 2 diabetes medicine in the U.S., showed an 8% lower rate of major heart events than Lilly's older drug Trulicity

originale

Timeline cronologica

venerdì 28 agosto 2026·healio.com
Mounjaro approved to reduce cardiovascular events in adults with diabetes
The FDA has approved tirzepatide for reduction of cardiovascular risk in adults with type 2 diabetes, Eli Lilly announced.Tirzepatide (Mounjaro), a dual GLP-1/glucose-dependent…
venerdì 28 agosto 2026·morningstar.com
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

FDA approves Mounjaro to lower heart attack and stroke risk

Confronto fonti

FDA approves Mounjaro to lower heart attack and stroke risk

Timeline cronologica

Mounjaro approved to reduce cardiovascular events in adults with diabetes

FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

Mounjaro Is Now Approved to Lower the Risk of Heart Events

FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks

Mounjaro approved to reduce cardiovascular events in adults with diabetes

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug

Regulador dos EUA aprova Mounjaro, da Eli Lilly, para reduzir risco cardiovascular

FDA approves Mounjaro to lower heart attack and stroke risk

Weight-loss drugs could help treat other health conditions. Here’s what could be next

Mounjaro Is Now Approved to Lower the Risk of Heart Events

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks